General Information of Drug (ID: DMB5LNC)

Drug Name
ISIS 19675 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMB5LNC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CL-387785 DMLKFZC Discovery agent N.A. Investigative [2]
ISIS 19657 DMGIMH8 Discovery agent N.A. Investigative [1]
ISIS 19650 DMCZLK1 Discovery agent N.A. Investigative [1]
ISIS 19647 DMS5PZ0 Discovery agent N.A. Investigative [1]
ISIS 19649 DMBEPGU Discovery agent N.A. Investigative [1]
ISIS 19677 DMN0DR2 Discovery agent N.A. Investigative [1]
ISIS 19658 DM8WC4A Discovery agent N.A. Investigative [1]
ISIS 19659 DMQ5UA3 Discovery agent N.A. Investigative [1]
ISIS 19651 DM8O7EM Discovery agent N.A. Investigative [1]
ISIS 19676 DMYEMST Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HER4 messenger RNA (ERBB4 mRNA) TTWALCO ERBB4_HUMAN Not Available [1]

References

1 US patent application no. 6,255,111, Antisense modulation of Her-4 expression.
2 Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB... J Med Chem. 2006 Feb 23;49(4):1475-85.